Citadel Advisors - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$13,471
-54.2%
18,973
-52.0%
0.00%
Q1 2023$29,395
+0.6%
39,500
-1.9%
0.00%
Q4 2022$29,214
+71.8%
40,257
+135.4%
0.00%
Q3 2022$17,000
-94.3%
17,100
-89.1%
0.00%
Q2 2022$299,000
+115.1%
156,496
+460.9%
0.00%
Q1 2022$139,000
-73.4%
27,900
-59.6%
0.00%
Q4 2021$522,000
-36.3%
69,103
-33.3%
0.00%
Q3 2021$819,000
-37.3%
103,630
+9.9%
0.00%
Q2 2021$1,307,000
-46.8%
94,267
-19.7%
0.00%
Q1 2021$2,456,000
+50.7%
117,351
+19.6%
0.00%
Q4 2020$1,630,000
+31.8%
98,136
+34.8%
0.00%
Q3 2020$1,237,000
+61.1%
72,784
+57.5%
0.00%
Q2 2020$768,00046,2210.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 315,668$1,272,1421.63%
MPM ASSET MANAGEMENT LLC 313,136$1,261,9380.68%
View complete list of HARPOON THERAPEUTICS INC shareholders